Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul;54(5):3578-3590.
doi: 10.1007/s12035-016-9910-6. Epub 2016 May 18.

Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury

Affiliations
Review

Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury

Hemant Kumar et al. Mol Neurobiol. 2017 Jul.

Abstract

The blood-spinal cord barrier (BSCB) is a specialized protective barrier that regulates the movement of molecules between blood vessels and the spinal cord parenchyma. Analogous to the blood-brain barrier (BBB), the BSCB plays a crucial role in maintaining the homeostasis and internal environmental stability of the central nervous system (CNS). After spinal cord injury (SCI), BSCB disruption leads to inflammatory cell invasion such as neutrophils and macrophages, contributing to permanent neurological disability. In this review, we focus on the major proteins mediating the BSCB disruption or BSCB repair after SCI. This review is composed of three parts. Section 1. SCI and the BSCB of the review describes critical events involved in the pathophysiology of SCI and their correlation with BSCB integrity/disruption. Section 2. Major proteins involved in BSCB disruption in SCI focuses on the actions of matrix metalloproteinases (MMPs), tumor necrosis factor alpha (TNF-α), heme oxygenase-1 (HO-1), angiopoietins (Angs), bradykinin, nitric oxide (NO), and endothelins (ETs) in BSCB disruption and repair. Section 3. Therapeutic approaches discusses the major therapeutic compounds utilized to date for the prevention of BSCB disruption in animal model of SCI through modulation of several proteins.

Keywords: Angiopoietins; Blood-spinal cord barrier; Bradykinin; HO-1; Matrix metalloproteinase; Spinal cord injury; TNF-α.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Neurochem. 2009 Jun;109 (6):1658-67 - PubMed
    1. J Neurotrauma. 2009 Aug;26(8):1369-78 - PubMed
    1. Dig Dis Sci. 2012 Jul;57(7):1792-801 - PubMed
    1. Cancer Res. 2001 Apr 15;61(8):3348-54 - PubMed
    1. Exp Neurol. 2015 May;267:152-64 - PubMed

Publication types

LinkOut - more resources

  NODES
admin 1
INTERN 1
twitter 2